摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(10R,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] dodecanoate

中文名称
——
中文别名
——
英文名称
[(10R,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] dodecanoate
英文别名
[(10R,13R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] dodecanoate
[(10R,13R,17R)-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] dodecanoate化学式
CAS
——
化学式
C39H68O2
mdl
——
分子量
569.0
InChiKey
RMLFYKFCGMSLTB-LUBMUSORSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    14.3
  • 重原子数:
    41
  • 可旋转键数:
    17
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.92
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • [EN] RAS BINDING PEPTIDES AND METHODS OF USE<br/>[FR] PEPTIDES DE LIAISON À RAS ET MÉTHODES D'UTILISATION
    申请人:RA PHARMACEUTICALS INC
    公开号:WO2017181061A1
    公开(公告)日:2017-10-19
    The present invention provides Ras modulators including inhibitors and/or antagonists of Ras, Ras binding, and Ras-dependent cell signaling activity. Also provided are methods of utilizing the Ras modulators as therapeutics.
    本发明提供了Ras调节剂,包括Ras的抑制剂和/或拮抗剂,以及Ras结合和Ras依赖的细胞信号活性。还提供了利用这些Ras调节剂作为治疗药物的方法。
  • IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF
    申请人:Nitto Denko Corporation
    公开号:US20160376229A1
    公开(公告)日:2016-12-29
    This invention includes ionizable compounds, and compositions and methods of use thereof. The ionizable compounds can be used for making nanoparticle compositions for use in biopharmaceuticals and therapeutics. More particularly, this invention relates to compounds, compositions and methods for providing nanoparticles to encapsulate active agents, such as nucleic acid agents, and to deliver and distribute the active agents to cells, tissues, organs, and subjects.
    这项发明涉及可离子化的化合物,以及其组合物和使用方法。这些可离子化的化合物可用于制备纳米粒子组合物,用于生物制药和治疗。更具体地说,这项发明涉及提供纳米粒子以包裹活性剂,如核酸剂,并将活性剂传递和分发到细胞、组织、器官和受试者的化合物、组合物和方法。
  • Functional associative coatings for nanoparticles
    申请人:Hainfeld James F.
    公开号:US20080089836A1
    公开(公告)日:2008-04-17
    Described herein are nanoparticles that are coated with a bilayer of molecules formed from surface binding molecules and amphiphatic molecules. The bilayer coating self assembles on the nanoparticles from readily available materials/molecules. The modular design of the bilayer coated nanoparticles provides a means for readily and efficiently optimizing the properties of the bilayer coated nanoparticle compositions. Also described herein are uses of such nanoparticles in medicine, laboratory techniques, industrial and commerical applications.
    本文描述了一种纳米颗粒,其表面涂覆有由表面结合分子和两亲分子形成的双层分子层。该双层涂层可以自组装在纳米颗粒上,使用易得的材料/分子。双层涂层纳米颗粒的模块化设计提供了一种方便和高效地优化其性质的方法。此外,本文还描述了这种纳米颗粒在医学、实验室技术、工业和商业应用中的用途。
  • Alpha-Isomaltosylglucosaccharide synthase, process for producing the same and use thereof
    申请人:——
    公开号:US20030194762A1
    公开(公告)日:2003-10-16
    The object of the present invention is to provide an &agr;-isomaltosylglucosaccharide-forming enzyme, process of the same, cyclotetrasaccharide, and saccharide composition comprising the saccharide which are obtainable by using the enzyme; and is solved by establishing an &agr;-isomaltosylglucosaccharide-forming enzyme which forms a saccharide, having a glucose polymerization degree of at least three and having both the &agr;-1,6 glucosidic linkage as a linkage at the non-reducing end and the &agr;-1,4 glucosidic linkage other than the linkage at the non-reducing end, by catalyzing the &agr;-glucosyl-transfer from a saccharide having a glucose polymerization degree of at least two and having the &agr;-1,4 glucosidic linkage as a linkage at the non-reducing end without substantially increasing the reducing power; &agr;-isomaltosyl-transferring method using the enzyme; method for forming &agr;-isomaltosylglucosaccharide; process for producing a cyclotetrasaccharide having the structure of cyclo{→6)-&agr;-D-glucopyranosyl-(1→3)-&agr;-D-glucopyranosyl-(1→6)-&agr;-D-glucopyranosyl-(1→3)-&agr;-D-glucopyranosyl-(1→} using both the &agr;-isomaltosylglucosaccharide-forming enzyme and the &agr;-isomaltosyl-transferring enzyme; and the uses of the saccharides obtainable therewith.
    本发明的目的是提供一种α-异麦芽糊精葡萄糖醛酸形成酶、其制备方法、环四糖和含有使用该酶可获得的糖分的糖组成物;并通过建立一种α-异麦芽糊精葡萄糖醛酸形成酶来解决该问题,该酶可形成一种葡萄糖聚合度至少为三且具有α-1,6葡萄糖苷键作为非还原端连接和α-1,4葡萄糖苷键作为非还原端连接以外的连接的糖分,通过催化具有至少二个葡萄糖聚合度且具有α-1,4葡萄糖苷键作为非还原端连接的糖分的α-葡萄糖基转移而形成,而不实质性地增加还原能力;使用该酶的α-异麦芽糊精转移方法;形成α-异麦芽糊精葡萄糖醛酸的方法;使用α-异麦芽糊精葡萄糖醛酸形成酶和α-异麦芽糊精转移酶同时制备具有环四糖结构的环四糖的方法;以及使用可获得的糖分的用途。
  • Sugar derivative
    申请人:——
    公开号:US20040254367A1
    公开(公告)日:2004-12-16
    For extending the uses of a compound represented by, Chemical formula 1, the object of the present invention is to provide a derivative of cyclic tetrasaccharide whose physicochemical properties are changed from those of cyclic tetrasaccaride, a composition comprising the same, and a process for producing the same. The present invention solves the above object by providing a derivative of cyclic tetrasaccharide, which is produced by the steps of reacting a compound represented by Chemical formula 1 with a reactive reagent and substituting one ore more hydroxyl groups with substituents except hydroxyl group and O-glycosyl group; a composition comprising the same; and a process for producing the derivative of cyclic tetrasaccharide. Chemical formula 1 1
    为了扩展化学式1所代表的化合物的用途,本发明的目的是提供一种环状四糖衍生物,其物理化学性质与环状四糖不同,以及包含该衍生物的组合物和制备该衍生物的方法。本发明通过以下步骤提供一种环状四糖衍生物:将化学式1代表的化合物与反应试剂反应,并用除了羟基和O-糖基以外的取代基替换一个或多个羟基;包含该衍生物的组合物;以及制备环状四糖衍生物的方法。化学式11。
查看更多